Study Day: 1 2 3 4 5 6 7 8 9 10 11 12             Did the participant receive a continuous Y Y Y Y Y Y Y Y Y Y Y Y             infusion of vasopressors or inotropes N N N N N N N N N N N N today? If yes, record the highest hourly infusion rate for each vasopressor/inotropes Dopamine (>5ug/kg/min) Dobutamine Norepinephrine Epinephrine Phenylephrine (>50ug/min) Vasopressin Milrinone Levosimendan
Study Day: 1 2 3 4 5 6 7 8 9 10 11 12 Did the participant receive a continuous infusion of vasopressors or inotropes today?  Y  N  Y  N  Y  N  Y  N  Y  N  Y  N  Y  N  Y  N  Y  N  Y  N  Y  N  Y  N If yes, record the highest hourly infusion rate for each vasopressor/inotropes Dopamine (>5ug/kg/min) Dobutamine Norepinephrine Epinephrine Phenylephrine (>50ug/min) Vasopressin Milrinone Levosimendan
Pt_CRF_WS_13-Nov-2017.docx